Form 4 for CRSP CRISPR Therapeutics AG
Accepted 2021-12-07 00:00:00 ET · period of report 2021-12-03 · accession 0001209191-21-068454 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-07 | 2021-12-03 | CRSP | Ho Tony W | Executive VP, Head of R, D | M - OptEx | — | +26.7K | 65.0K | +70% | — |
| D | 2021-12-07 | 2021-12-06 | CRSP | Ho Tony W | Executive VP, Head of R, D | F - Tax | $69.17 | -12.6K | 52.4K | -19% | -$872.0K |
| D | 2021-12-07 | 2021-12-03 | CRSP | Ho Tony W | Executive VP, Head of R, D | M - OptEx | — | +26.7K | 13.3K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2021-12-03 | M | A | 26,667 | — | 64,971 | D | — | — | (F1) The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. (F2) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. |
| 2 | Common | Common Shares | 2021-12-06 | F | D | 12,607 | $69.17 | 52,364 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2021-12-03 | M | A | 26,667 | — | 13,333 | D | — · — to — | 26,667 Common Shares | (F2) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. (F1) The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. |